Article
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.
European journal of clinical pharmacology - 1 Feb 2022
Merćep Iveta, Radman Ivana, Trkulja Vladimir, Božina Tamara, Šimičević Livija, Budimir Ema, Ganoci Lana, Božina Nada
Abstract excerpt
PURPOSE: The study aims to evaluate relationship between polymorphisms associated with a reduced function of two transporter proteins resulting in increased exposure to rosuvastatin - organic anion transporter 1B1 (OATP1B1) (SLCO1B1 c.521T>C) and ATP binding cassette subfamily G member 2 (ABCG2) (ABCG2 c.421C>A) and occurrence of rosuvastatin related myotoxicity/hepatotoxicity. METHODS: In a case-control study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
